Journals / İstanbul Medical Journal / 2016 / Cilt: 17 - Sayı: 2

Diagnostic Value of Adenosine Deaminase Level for the Differential Diagnosis of Tuberculosis and Malignancy in Exudative Lymphocytic Pleurisy

Eksudatif Lenfositik Plevral Sıvılarda Tüberküloz ve Malignite Ayırımında Adenozin Deaminaz Düzeyinin Tanısal Değeri

Pages
59–63
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this group, reducing the conventional cut-off value and/or performing an age-based approach seems to improve the diagnostic performance of ADA levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the diagnostic performance of adenosine deaminase (ADA) levels in patients with exudative lymphocytic pleurisy for the differential diagnosis of tuberculous pleurisy (TBP) and malignant pleural effusion (MPE).
📊
Key Findings & Data:The study population comprised 54 patients.
💡
Conclusion & Impact:In this group, reducing the conventional cut-off value and/or performing an age-based approach seems to improve the diagnostic performance of ADA levels.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the diagnostic performance of adenosine deaminase (ADA) levels in patients with exudative lymphocytic pleurisy for the differential diagnosis of tuberculous pleurisy (TBP) and malignant pleural effusion (MPE). Methods: Data on patients with exudative lymphocytic pleurisy were retrospectively analyzed. The study population comprised 54 patients. Thirtyseven were diagnosed with TBP and 17 were diagnosed with MPE. Results: Significant differences were determined in terms of age and ADA, total protein, albumin, and LDH levels between the TBP and MPE groups. The optimal cut-off value of ADA levels was 35.1 U/L for diagnosing TBP. Sensitivity and specificity were 92% and 100%, respectively. Logistic regression analysis was performed to assess independent variables associated with TBP. Independent predictive factors in the model were ADA (OR: 1.21, 95% CI: 1.06-1.39, p=0.006)], and (OR: 0.92, 95% CI: 0.84-1.00, p = 0.052)]. The AUC value by the regression equation was 0.979 (p13.51 and >35.1) for each age range were found in all, but one, TBP patients. Conclusion: ADA levels are useful for the diagnosis of TBP in cases where pleural biopsy cannot be performed or that are inconclusive in making a diagnosis of TBP. In this group, reducing the conventional cut-off value and/or performing an age-based approach seems to improve the diagnostic performance of ADA levels.

Özet

Amaç: Plevra sıvısı eksudatif-lenfositik özellik gösteren olguların Tüberkuloz plörezi (TBP) ve Malign plörezi (MP) ayırımında adenozin-deaminaz (ADA) düzeyinin tanısal performansını değerlendirmek. Yöntemler: Eksudatif-lenfositik plörezili olguları içeren doktora tez çalışmasının verileri retrospektif olarak değerlendirildi. Çalışma populasyonu 37'si TBP, 17'si MP olmak üzere toplam 54 olguyu içeriyordu. Bulgular: TBP ve MP grubu arasında yaş, ADA, total protein, albumin ve LDH düzeyi açısından anlamlı farklılık gözlendi. ADA cut off düzeyi 35,1 olarak belirlendi. Bu cut off düzeyi için sensitivite ve spesifite sırasıyla %92 ve %100 olarak bulundu. TBP ile ilişkili bağımsız değişkenleri değerlendirmek için lojistik regresyon analizi yapıldı. Modelde bağımsız tahmin ettirici faktörler olarak ADA (OR 1,21, 95% GA: 1,06-1,39, p=0,006)] ve yaş (OR 0,92, 95% GA:0,84-1,00, p=0,052)] kaldı. Regresyon denkleminin AUC değeri 0,979 olarak bulundu (p13,51, >35,1) ile bir hasta haricinde tüm TBP'li olgulara tanı konulabilmekteydi. Sonuç: Plevral ADA düzey ölçümü biopsi işleminin yapılamadığı veya sonuçsuz kaldığı durumlarda TBP tanısı için oldukça faydalı bir testtir. Bahsedilen grupta ADA için konvansiyonel cut off düzeyini düşürmek ve/veya yaş bazlı yaklaşım bu testin tanısal performansını artırıyor gözükmektedir.

🔖

Cite This Article

ALTINSOY, B., ÜNVER, E., MİHMANLI, A., AKKAYA, E., GÜNGÖR, S., YALÇINSOY, M. (2022). Diagnostic Value of Adenosine Deaminase Level for the Differential Diagnosis of Tuberculosis and Malignancy in Exudative Lymphocytic Pleurisy. İstanbul Medical Journal, Cilt: 17 - Sayı: 2, 59–63. https://ajindex.com/articles/550344

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Mayse ML. Non-malignant pleural effusions. In: Fishman AP, editor. Fishman's Pulmonary Diseases and Disorders. 1. New York: McGraw- Hill; 2008. p.1487-504. Light RW. Approach to the Patient In: Light RW, editor. Pleural diseases. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p.109-19.
  2. Cohen LA, Light RW. Tuberculous Pleural Effusion. Turkish Thoracic Journal 2015;16(1). Diacon AH, Van de Wal BW, Wyser C, Smedema JP, Bezuidenhout J, Bolliger CT, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22: 589-91. [CrossRef] Baganha MF, Pêgo A, Lima MA, Gaspar EV, Cordeiro AR. Serum and pleural adenosine deaminase. Correlation with lymphocytic popula- tions. Chest 1990; 97: 605-10. [CrossRef] Goto M, Noguchi Y, Koyama H, Hira K, Shimbo T, Fukui T. Diagnos- tic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann Clin Biochem 2003; 40: 374-81. [CrossRef] Atalay F, Ernam D, Hasanoglu HC, Karalezli A, Kaplan O. Pleural ad- enosine deaminase in the separation of transudative and exudative pleural effusions. Clin Biochem 2005; 38: 1066-70. [CrossRef] Krenke R, Korczy'ski P. Use of pleural fluid levels of adenosine deami- nase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med 2010; 16: 367-75. [CrossRef] Giusti G, Galanti B. Colorimetric method. In: H.U.Bergmeyer, edi- tor. Methods of enzymatic analysis Weinheim: Verlag Chemie; 1984. p.315-23. Light RW. Update on tuberculous pleural effusion. Respirology 2010; 15: 451-8. [CrossRef] Frank W. Tuberculous pleural effusions. Eur Respir Mon 2002; 22: 219-33.
  3. Porcel JM, Alemán C, Bielsa S, Sarrapio J, Fernández de Sevilla T, Es- querda A. A decision tree for differentiating tuberculous from malig- nant pleural effusions. Respir Med 2008; 102: 1159-64. [CrossRef] Porcel JM, Vives M. Differentiating tuberculous from malignant pleu- ral effusions: a scoring model. Med Sci Monit 2003; 9: CR175-80. Saiphoklang N, Kanitsap A, Nambunchu A. Differences in clinical manifestations and pleural fluid charateristics between tuberculous and malignant pleural effusions. Southeast Asian J Trop Med Public Health 2015; 46: 496-503.
  4. Sales RKB, Vargas FS, Capelozzi VL, Seiscento M, Genofre EH, Teixeira LR, et al. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer. Respirology 2009; 14: 1128-33. [CrossRef] Özlü T. Plevra Sıvılarında Tanı. Toraks Dergisi 2000; 2: 85-94.
  5. Vorster MJ, Allwood B